Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-26
2009-12-29
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S331000, C546S209000, C548S203000, C548S252000
Reexamination Certificate
active
07638541
ABSTRACT:
Compounds, compositions, and methods relating to 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof are provided for the treatment of Type II diabetes and other diseases associated with poor glycemic control.
REFERENCES:
patent: 5817677 (1998-10-01), Linz et al.
patent: 6221660 (2001-04-01), Bonini et al.
patent: 6468756 (2002-10-01), Bonini et al.
patent: 7108991 (2006-09-01), Chen et al.
patent: 2002/0198223 (2002-12-01), Allerton et al.
patent: 2003/0064990 (2003-04-01), Denton et al.
patent: 2005/0165005 (2005-07-01), Genevois-Borella et al.
patent: 2006/0135501 (2006-06-01), Knox et al.
patent: 1092727 (2001-04-01), None
patent: 1129706 (2001-09-01), None
patent: 1176147 (2002-01-01), None
patent: 1133559 (2005-08-01), None
patent: 1584683 (2007-07-01), None
patent: 1813606 (2007-08-01), None
patent: WO 00/50562 (2000-08-01), None
patent: WO 2005/061489 (2005-07-01), None
patent: WO 2006/076231 (2006-07-01), None
patent: WO 2006/124692 (2006-11-01), None
patent: WO 2007/003960 (2007-01-01), None
patent: WO 2007/023507 (2007-03-01), None
patent: WO 2007/039177 (2007-04-01), None
patent: WO 2007/120702 (2007-10-01), None
Deng et al. “A novel and efficient synthesis of 2,5-substituted 1,2,4-triazol-3-ones” Tetrahedron Letters, vol. 46, No. 46, 2005, pp. 7993-7996, XP005113190.
Soga et al., “Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.” Biochem. Biophys Res Commun., Jan. 28, 2005, vol. 326, No. 4, pp. 744-751.
Chen Xin
Cheng Peng
Clemens L. Edward
Johnson Jeffrey D.
Ma Jingyuan
Metabolex Inc.
Suh Gerald
Swiss Tanner, P.C.
Willis Douglas M
Wilson James O
LandOfFree
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107372